Air Liquide supplies industrial and medical gases, including oxygen and hydrogen, to customers and patients across healthcare, manufacturing, energy transition and other sectors. Operating in 60 countries with 66,500 employees, the company serves more than 4 million customers and patients globally. Its core products include industrial gases for manufacturing processes, medical gases for hospital care and patient treatment, and hydrogen for clean transportation and low-carbon energy solutions.
The company maintains six global R&D campuses dedicated to developing technologies that address energy transition, resource efficiency and healthcare access. Air Liquide's technical focus spans hydrogen technologies, low-carbon energy solutions and CO2 reduction innovations alongside its established industrial and medical gas operations. With over 120 years of operational history, the company positions itself as a provider of essential molecules fundamental to progress across multiple industries.
Air Liquide's strategy, termed ADVANCE, emphasises accelerating the energy transition, advancing healthcare access and delivering sustained performance. The company frames its role around addressing climate change, resource scarcity and evolving healthcare needs through its gas supply networks and enabling technologies.
